{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:04:13Z","timestamp":1793289853469,"version":"4.5.0"},"reference-count":6,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s40261-025-01503-1","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:16:19Z","timestamp":1762953379000},"page":"237-240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bumetanide Nasal Spray: First Approval"],"prefix":"10.1007","volume":"46","author":[{"given":"Hannah A.","family":"Blair","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"issue":"10","key":"1503_CR1","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/CIRCULATIONAHA.124.072949","volume":"151","author":"AP Ambrosy","year":"2025","unstructured":"Ambrosy AP, Bensimhon D, Bernstein G, et al. Randomized study comparing a novel intranasal formulation of bumetanide with oral and intravenous formulations. Circulation. 2025;151(10):737\u201340.","journal-title":"Circulation"},{"issue":"4","key":"1503_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jacbts.2023.03.002","volume":"8","author":"B Esque","year":"2023","unstructured":"Esque B, Adler ED, Bensimhon D. Novel intranasal loop diuretic. JACC Basic Transl Sci. 2023;8(4):383\u20135.","journal-title":"JACC Basic Transl Sci"},{"key":"1503_CR3","unstructured":"BusinessWire. Corstasis Therapeutics announces FDA approval of ENBUMYST\u2122 (bumetanide nasal spray) for the treatment of edema associated with congestive heart failure, liver disease and kidney disease [media release]. 15 Sep 2025. https:\/\/www.businesswire.com\/news\/home\/20250915243998\/en\/Corstasis-Therapeutics-Announces-FDA-Approval-of-ENBUMYST-bumetanide-nasal-spray-for-the-Treatment-of-Edema-Associated-with-Congestive-Heart-Failure-Liver-Disease-and-Kidney-Disease."},{"key":"1503_CR4","unstructured":"BusinessWire. Corstasis Therapeutics Inc. announces FDA acceptance of New Drug Application for bumetanide nasal spray [media release]. 27 Jan 2025. https:\/\/www.businesswire.com\/news\/home\/20250126982238\/en\/Corstasis-Therapeutics-Inc.-Announces-FDA-Acceptance-of-New-Drug-Application-for-Bumetanide-Nasal-Spray."},{"key":"1503_CR5","unstructured":"Corstasis Therapeutics. ENBUMYST (bumetanide nasal spray): US prescribing information. 2025. https:\/\/corstasis.com\/wp-content\/uploads\/2025\/09\/Enbumyst_bumetanide_nasal_spray_PI_12Sept25.pdf. Accessed 23 Oct 2025."},{"key":"1503_CR6","unstructured":"BusinessWire. Corstasis Therapeutics announces allowance of a new patent and development updates for subcutaneous programs RSQ-786 and RSQ-789 [media release]. 3 Sep 2025. https:\/\/www.businesswire.com\/news\/home\/20250902731398\/en\/Corstasis-Therapeutics-Announces-Allowance-of-a-New-Patent-and-Development-Updates-for-Subcutaneous-Programs-RSQ-786-and-RSQ-789."}],"updated-by":[{"DOI":"10.1007\/s40261-025-01514-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000}}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01503-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-025-01503-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-025-01503-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T04:35:18Z","timestamp":1770179718000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-025-01503-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["1503"],"URL":"https:\/\/doi.org\/10.1007\/s40261-025-01503-1","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Incorrect\nfigure legends were updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40261-025-01514-y","URL":"https:\/\/doi.org\/10.1007\/s40261-025-01514-y","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the peer review process, the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Hannah Blair is a salaried employee of Adis International Ltd\/Springer Nature and declares no relevant conflicts of interest. All authors contributed to this article and are responsible for its content.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authorship and Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, Consent to participate, Consent to publish, Availability of data and material, Code availability"}}]}}